Katie Hammond
Internal Medicine · Lansing, MINPI 1225371909
Payments from drug & device makers
Across 83 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Welch Allyn$192
- Novo Nordisk$162
- AbbVie$150
- Pfizer$124
- Lilly USA, LLC$107
- GSK$89
- plus $810 from 28 others
What the payments were for
- Food & beverage$1,42787%
- Education$151%
- Other$19212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Welch Allyn | 1 | $192 |
| Novo Nordisk | 9 | $162 |
| AbbVie | 8 | $150 |
| Pfizer | 7 | $124 |
| Lilly USA, LLC | 7 | $107 |
| GSK | 5 | $89 |
| Novartis | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 4 | $65 |
| Merck | 4 | $62 |
| AstraZeneca | 3 | $51 |
| Boston Scientific | 2 | $46 |
| Antares Pharma, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 3 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $35 |
| BD | 1 | $32 |
| Grifols USA, LLC | 1 | $25 |
| Mylan Specialty L.p. | 1 | $24 |
| Viatris Specialty LLC | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Clarus Therapeutics Inc. | 1 | $20 |
| Nevro Corp. | 1 | $19 |
| Bayer | 1 | $18 |
| Medtronic | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Insmed, Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Insulet Corporation | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$192
How this compares
$1,634 in reported general payments places this provider in the 80th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 36 | $58,224 |
| MounjaroTirzepatide | 48 | $58,025 |
| JanuviaSitagliptin Phosphate | 47 | $57,574 |
| FarxigaDapagliflozin Propanediol | 41 | $48,317 |
| JardianceEmpagliflozin | 39 | $44,759 |
| OzempicSemaglutide | 36 | $44,756 |
| EliquisApixaban | 46 | $33,721 |
| XareltoRivaroxaban | 28 | $28,395 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $25,165 |
| MyrbetriqMirabegron | 25 | $17,282 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $10,727 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $4,712 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $4,665 |
| PremarinEstrogens, Conjugated | 14 | $4,657 |
| Levothyroxine Sodium | 326 | $3,922 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $107 | $116,24984 claims |
| MerckJanuvia | $62 | $57,57447 claims |
| AstraZenecaFarxiga | $51 | $48,31741 claims |
| Novo NordiskOzempic | $162 | $44,75636 claims |
| PfizerEliquis, Premarin | $124 | $38,37860 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $89 | $35,89235 claims |
| Johnson & JohnsonXarelto | $14 | $28,39528 claims |
| Astellas Pharma US IncMyrbetriq | $39 | $17,28225 claims |
| AbbVieSynthroid | $150 | $1,13118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Lansing
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Ahmed ArifFlint$4.1M
- Sudipto MukherjeeRoyal Oak$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.